Charles Albright
2017
In 2017, Charles Albright earned a total compensation of $1.3M as Chief Scientific Officer at Editas Medicine, a 53% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $113,498 |
|---|---|
| Option Awards | $765,513 |
| Salary | $379,275 |
| Other | $8,349 |
| Total | $1,266,635 |
Albright received $765.5K in option awards, accounting for 60% of the total pay in 2017.
Albright also received $113.5K in non-equity incentive plan, $379.3K in salary and $8.3K in other compensation.
Rankings
In 2017, Charles Albright's compensation ranked 7,834th out of 14,666 executives tracked by ExecPay. In other words, Albright earned more than 46.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,834 out of 14,666 | 47th |
Division Manufacturing | 2,939 out of 5,772 | 49th |
Major group Chemicals And Allied Products | 957 out of 2,075 | 54th |
Industry group Drugs | 744 out of 1,731 | 57th |
Industry Biological Products, Except Diagnostic Substances | 139 out of 313 | 56th |
Source: SEC filing on April 26, 2019.
Albright's colleagues
We found three more compensation records of executives who worked with Charles Albright at Editas Medicine in 2017.